Combination therapy with glutaminase inhibitors and immuno-oncology agents

Combination therapy with glutaminase inhibitors and immuno-oncology agents

The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bennett, Mark K, Bromley, Susan D, Parlati, Francesco, Molineaux, Susan M, Gross, Matthew I
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bennett, Mark K
Bromley, Susan D
Parlati, Francesco
Molineaux, Susan M
Gross, Matthew I
description The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10258619B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10258619B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10258619B23</originalsourceid><addsrcrecordid>eNqNyjEKwkAQQNFtLES9w3iAgIko2hoUsVXrMImT7EB2ZslOkNxeCw9g9Yv35-5WaqhZ0FgFzNOAcYI3m4euHw3DlxIBi-eaTYcEKC_gEEbRTKXRXrsJsCOxtHSzFvtEq18Xbn05P8prRlErShEbErLqec83xe6wz4-nYvvP8wGW-jYn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Combination therapy with glutaminase inhibitors and immuno-oncology agents</title><source>esp@cenet</source><creator>Bennett, Mark K ; Bromley, Susan D ; Parlati, Francesco ; Molineaux, Susan M ; Gross, Matthew I</creator><creatorcontrib>Bennett, Mark K ; Bromley, Susan D ; Parlati, Francesco ; Molineaux, Susan M ; Gross, Matthew I</creatorcontrib><description>The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190416&amp;DB=EPODOC&amp;CC=US&amp;NR=10258619B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190416&amp;DB=EPODOC&amp;CC=US&amp;NR=10258619B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bennett, Mark K</creatorcontrib><creatorcontrib>Bromley, Susan D</creatorcontrib><creatorcontrib>Parlati, Francesco</creatorcontrib><creatorcontrib>Molineaux, Susan M</creatorcontrib><creatorcontrib>Gross, Matthew I</creatorcontrib><title>Combination therapy with glutaminase inhibitors and immuno-oncology agents</title><description>The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQQNFtLES9w3iAgIko2hoUsVXrMImT7EB2ZslOkNxeCw9g9Yv35-5WaqhZ0FgFzNOAcYI3m4euHw3DlxIBi-eaTYcEKC_gEEbRTKXRXrsJsCOxtHSzFvtEq18Xbn05P8prRlErShEbErLqec83xe6wz4-nYvvP8wGW-jYn</recordid><startdate>20190416</startdate><enddate>20190416</enddate><creator>Bennett, Mark K</creator><creator>Bromley, Susan D</creator><creator>Parlati, Francesco</creator><creator>Molineaux, Susan M</creator><creator>Gross, Matthew I</creator><scope>EVB</scope></search><sort><creationdate>20190416</creationdate><title>Combination therapy with glutaminase inhibitors and immuno-oncology agents</title><author>Bennett, Mark K ; Bromley, Susan D ; Parlati, Francesco ; Molineaux, Susan M ; Gross, Matthew I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10258619B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Bennett, Mark K</creatorcontrib><creatorcontrib>Bromley, Susan D</creatorcontrib><creatorcontrib>Parlati, Francesco</creatorcontrib><creatorcontrib>Molineaux, Susan M</creatorcontrib><creatorcontrib>Gross, Matthew I</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bennett, Mark K</au><au>Bromley, Susan D</au><au>Parlati, Francesco</au><au>Molineaux, Susan M</au><au>Gross, Matthew I</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Combination therapy with glutaminase inhibitors and immuno-oncology agents</title><date>2019-04-16</date><risdate>2019</risdate><abstract>The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10258619B2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Combination therapy with glutaminase inhibitors and immuno-oncology agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A13%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bennett,%20Mark%20K&rft.date=2019-04-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10258619B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true